- ￥3113
- OriGene
- 美国
- AM08146PU-N
- 2026年04月01日
- ELISA, IF, IHC, WB
- Mouse
- Human
企业认证
相关产品推荐更多 >
LMO2 mouse monoclonal antibody, clone OTI1C8 (formerly 1C8)
￥1999
p35 (CDK5R1) rabbit polyclonal antibody, Aff - Purified
￥2700
CD103 hamster monoclonal antibody, clone 2E7, Low Endotoxin
￥5302MET pTyr1349 rabbit polyclonal antibody, Aff - Purified
￥1400
PTPRE mouse monoclonal antibody, clone OTI4B2 (formerly 4B2), HRP conjugated
￥3990
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
细胞污染识别与处理全攻略：5 种常见类型+关键误区Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 形态：
100 mM Borate Buffered Saline, pH 8.2.No preservatives or amine-containing buffer salts added.State: PurifiedState: Liquid purified Ig fraction.
- 保存条件：
Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.Avoid repeated freezing and thawing.
- 克隆性：
Monoclonal
- 适应物种：
Human
- 保质期：
Stable for 12 months from date of receipt.
- 目录编号：
AM08146PU-N
- 级别：
科研级
- 库存：
4周
- 供应商：
OriGene
- 宿主：
Mouse
- 应用范围：
ELISA, IF, IHC, WB
- 抗体英文名：
Human IgM (Mu chain specific) mouse monoclonal antibody, clone UHB, Purified
- 抗体名：
Human IgM (Mu chain specific) mouse monoclonal antibody, clone UHB, Purified
- 规格：
500 ug
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Isolation of Human Monoclonal Antibodies Using Guided Selection with Mouse Monoclonal Antibodies
Repertoires of antibody (Ab) V genes derived from nonimmunized human donors (1 ) or made synthetically (2 3 ) have been cloned for display on filamentous bacteriophage as either scFvs or Fabs fused to the minor phage coat protein (pIII
Rapid Isotyping of Mouse Monoclonal Antibodies
Determination of class and subclass of monoclonal antibodies (MAbs) is important because several immunochemical and functional properties of antibodies depend on the isotype. Knowledge of the light-chain isotype (κ for 95% or λ
【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
技术资料暂无技术资料 索取技术资料
